Related Experiment Video
Updated: Jul 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression
Katharina H Ruebel1, Alexey A Leontovich, Yoshinori Tanizaki
1Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA.
Abstract:
The pathogenesis of pituitary adenomas and many of the genes influencing growth of these tumors are unknown. TGFbeta is known to inhibit proliferation of cultured anterior pituitary cells and anterior pituitary tumors, but the signal transduction pathways involved in the inhibition of growth are unclear. We treated the human HP75 pituitary cell line with 10(-9) M TGFbeta1 for 4, 24, and 96 h and performed global gene expression profiling by Affymetrix GeneChip microarray analysis. Quantitative PCR validation of specific genes involved in the TGFbeta1-induced regulation of pituitary cell growth was also done. Of the 15,000 genes queried, there were 37 genes up-regulated and 48 genes down-regulated twofold or more after 4 h of TGFbeta1 treatment. There were 121 genes up-regulated and 109 genes down-regulated twofold or more after 24 h of TGFbeta1 treatment and 112 genes up-regulated and 43 genes down-regulated twofold or more after 96 h of TGFbeta1 treatment. Galectin-3 (Gal-3) protein was decreased by TGFbeta1 treatment and several genes which interacted with Gal-3 including RUNX1 and WNT5B were up-regulated after TGFbeta1 treatment. SOX4 was also up-regulated by TGFbeta1 treatment. SMAD3, which is directly involved in the TGFbeta signal transduction pathway, was down-regulated by TGFbeta1 treatment. These findings highlight the diverse gene networks and pathways through which TGFbeta operates in its effects on pituitary tumor cells.
Insights
Transforming growth factor-beta (TGFβ) impacts pituitary tumor cell growth by altering gene expression. This study reveals TGFβ influences diverse gene networks, including those interacting with Galectin-3, impacting pituitary adenoma development.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- The precise mechanisms driving pituitary adenoma pathogenesis and growth remain largely unknown.
- Transforming growth factor-beta (TGFβ) is recognized for inhibiting anterior pituitary cell and tumor proliferation, yet its signal transduction pathways are not fully elucidated.
Purpose of the Study:
- To investigate the global gene expression changes in a human pituitary cell line following TGFβ1 treatment.
- To identify specific genes and pathways regulated by TGFβ1 that influence pituitary tumor cell growth.
Main Methods:
- Global gene expression profiling using Affymetrix GeneChip microarray analysis on the HP75 pituitary cell line treated with TGFβ1.
- Quantitative PCR was employed for validating specific gene expression alterations.
Main Results:
- TGFβ1 treatment led to significant alterations in the expression of numerous genes, with hundreds of genes being up-regulated or down-regulated at various time points (4, 24, and 96 hours).
- Key findings include decreased Galectin-3 (Gal-3) protein levels and up-regulation of interacting genes like RUNX1 and WNT5B, as well as SOX4.
- Notably, SMAD3, a crucial component of the TGFβ signaling pathway, was down-regulated by TGFβ1 treatment.
Conclusions:
- TGFβ exerts its inhibitory effects on pituitary tumor cells through complex and diverse gene networks.
- The study elucidates novel pathways involved in TGFβ-mediated regulation of pituitary cell growth, offering insights into pituitary adenoma pathogenesis.
Related Concept Videos
TGF - β Signaling Pathway
Reporter Genes
Commonly used reporter...
